UBS Group’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.02M | Buy |
1,412,099
+260,952
| +23% | +$1.11M | ﹤0.01% | 2906 |
|
|
2025
Q1 | $4.33M | Buy |
1,151,147
+590,641
| +105% | +$2.22M | ﹤0.01% | 3077 |
|
|
2024
Q4 | $3.27M | Buy |
560,506
+482,959
| +623% | +$2.82M | ﹤0.01% | 3321 |
|
|
2024
Q3 | $926K | Sell |
77,547
-81,078
| -51% | -$968K | ﹤0.01% | 3650 |
|
|
2024
Q2 | $1.72M | Sell |
158,625
-14,536
| -8% | -$157K | ﹤0.01% | 2979 |
|
|
2024
Q1 | $1.96M | Buy |
173,161
+120,663
| +230% | +$1.37M | ﹤0.01% | 3009 |
|
|
2023
Q4 | $737K | Buy |
52,498
+38,495
| +275% | +$540K | ﹤0.01% | 3669 |
|
|
2023
Q3 | $173K | Buy |
14,003
+12,493
| +827% | +$154K | ﹤0.01% | 4353 |
|
|
2023
Q2 | $13.6K | Buy |
1,510
+1,154
| +324% | +$10.4K | ﹤0.01% | 5961 |
|
|
2023
Q1 | $1.24K | Sell |
356
-3,732
| -91% | -$12.9K | ﹤0.01% | 7675 |
|
|
2022
Q4 | $10K | Buy |
4,088
+1,657
| +68% | +$4.06K | ﹤0.01% | 7391 |
|
|
2022
Q3 | $7K | Buy |
+2,431
| New | +$7K | ﹤0.01% | 7787 |
|
|
2022
Q2 | – | Sell |
-26
| Closed | – | – | 9572 |
|
|
2022
Q1 | $0 | Sell |
26
-104
| -80% | – | ﹤0.01% | 9470 |
|
|
2021
Q4 | $1K | Buy |
+130
| New | +$1K | ﹤0.01% | 8874 |
|
|
2021
Q2 | – | Sell |
-636
| Closed | -$21K | – | 8480 |
|
|
2021
Q1 | $21K | Sell |
636
-52,617
| -99% | -$1.74M | ﹤0.01% | 6321 |
|
|
2020
Q4 | $2.56M | Buy |
+53,253
| New | +$2.56M | ﹤0.01% | 2419 |
|